VG901
/ ViGeneron
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
March 28, 2025
Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene
(clinicaltrials.gov)
- P1 | N=6 | Recruiting | Sponsor: ViGeneron GmbH | Trial completion date: Dec 2025 ➔ Apr 2026 | Trial primary completion date: Dec 2025 ➔ Apr 2026
Trial completion date • Trial primary completion date • Genetic Disorders • Inherited Retinal Dystrophy • Ocular Inflammation • Ophthalmology • Retinal Disorders • Retinitis Pigmentosa
January 08, 2025
ViGeneron Announces FDA Rare Pediatric Disease Designation for VG901 and DSMB Approval to Advance Dose Escalation in Phase 1b Retinitis Pigmentosa Trial
(GlobeNewswire)
- "ViGeneron GmbH...announced two important milestones for its novel gene therapy candidate VG901, to treat patients with retinitis pigmentosa (RP) caused by mutations in the CNGA1 gene. The U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to VG901, and the independent Data Safety Monitoring Board (DSMB) has unanimously approved dose escalation in the ongoing Phase 1b clinical trial."
DSMB • FDA event • Retinitis Pigmentosa
April 10, 2024
ViGeneron Announces First Patient Dosed in Phase 1b Clinical Trial of VG901 for the Intravitreal Treatment of Retinitis Pigmentosa
(GlobeNewswire)
- "ViGeneron GmbH...today announced that the first patient has been dosed in its Phase Ib clinical trial evaluating intravitreal injection of VG901 to treat retinitis pigmentosa (RP) caused by mutations in the CNGA1 gene....VG901 has also been granted FDA Orphan Drug Designation status."
Orphan drug • Trial status • Retinitis Pigmentosa
March 04, 2024
Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene
(clinicaltrials.gov)
- P1 | N=6 | Recruiting | Sponsor: ViGeneron GmbH
New P1 trial • Genetic Disorders • Inherited Retinal Dystrophy • Ocular Inflammation • Ophthalmology • Retinal Disorders • Retinitis Pigmentosa
1 to 4
Of
4
Go to page
1